Jeffrey P. Whitten

2.9k total citations
45 papers, 1.8k citations indexed

About

Jeffrey P. Whitten is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Jeffrey P. Whitten has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 21 papers in Molecular Biology and 6 papers in Pharmaceutical Science. Recurrent topics in Jeffrey P. Whitten's work include Chemical Synthesis and Analysis (10 papers), Fluorine in Organic Chemistry (6 papers) and Synthesis and Biological Evaluation (6 papers). Jeffrey P. Whitten is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Fluorine in Organic Chemistry (6 papers) and Synthesis and Biological Evaluation (6 papers). Jeffrey P. Whitten collaborates with scholars based in United States, Czechia and United Kingdom. Jeffrey P. Whitten's co-authors include James R. McCarthy, Michael K. Schwaebe, Ian A. McDonald, Bruce M. Baron, Donald P. Matthews, Laurie E. Lambert, William G. Rice, Adam Siddiqui-Jain, Kenna Anderes and Chris Proffitt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and FEBS Letters.

In The Last Decade

Jeffrey P. Whitten

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey P. Whitten United States 21 918 496 274 204 168 45 1.8k
Irmgard Wiesenberg Switzerland 17 584 0.6× 194 0.4× 276 1.0× 330 1.6× 77 0.5× 26 1.7k
Albert J. Robichaud United States 29 1.1k 1.2× 1.1k 2.3× 273 1.0× 742 3.6× 64 0.4× 74 2.8k
Gilbert Lavielle France 25 768 0.8× 460 0.9× 193 0.7× 679 3.3× 40 0.2× 55 1.9k
Federica Vacondio Italy 29 829 0.9× 543 1.1× 155 0.6× 369 1.8× 71 0.4× 85 2.1k
John Saunders United States 28 1.3k 1.4× 1.3k 2.7× 124 0.5× 410 2.0× 111 0.7× 139 3.1k
Francesco G. Salituro United States 27 923 1.0× 357 0.7× 64 0.2× 462 2.3× 103 0.6× 45 1.8k
J.S. Dileep Kumar United States 26 586 0.6× 648 1.3× 156 0.6× 570 2.8× 69 0.4× 99 2.0k
Dino Nisato France 24 857 0.9× 367 0.7× 130 0.5× 239 1.2× 152 0.9× 77 2.2k
Alexander Scriabine United States 21 974 1.1× 335 0.7× 371 1.4× 565 2.8× 45 0.3× 112 2.1k
Jon E. Hawkinson United States 25 856 0.9× 353 0.7× 97 0.4× 885 4.3× 126 0.8× 74 1.8k

Countries citing papers authored by Jeffrey P. Whitten

Since Specialization
Citations

This map shows the geographic impact of Jeffrey P. Whitten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey P. Whitten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey P. Whitten more than expected).

Fields of papers citing papers by Jeffrey P. Whitten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey P. Whitten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey P. Whitten. The network helps show where Jeffrey P. Whitten may publish in the future.

Co-authorship network of co-authors of Jeffrey P. Whitten

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey P. Whitten. A scholar is included among the top collaborators of Jeffrey P. Whitten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey P. Whitten. Jeffrey P. Whitten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drygin, Denis, Adam Siddiqui-Jain, Sean O’Brien, et al.. (2009). Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis. Cancer Research. 69(19). 7653–7661. 462 indexed citations
2.
Fellows, I.M., Michael K. Schwaebe, Thomas S. Dexheimer, et al.. (2005). Determination of the importance of the stereochemistry of psorospermin in topoisomerase II–induced alkylation of DNA and in vitro and in vivo biological activity. Molecular Cancer Therapeutics. 4(11). 1729–1739. 17 indexed citations
3.
Rice, William G., Michael K. Schwaebe, Adam Siddiqui-Jain, et al.. (2005). Clinical development of CX-3543, a novel multi-targeting antitumor agent. Journal of Clinical Oncology. 23(16_suppl). 3206–3206. 7 indexed citations
4.
Huang, Charles Q., Dimitri E. Grigoriadis, Zhengyu Liu, et al.. (2004). Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor 1 (CRF 1 ) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2083–2086. 8 indexed citations
5.
Kiankarimi, Mehrak, Richard F. Lowe, James R. McCarthy, & Jeffrey P. Whitten. (1999). ChemInform Abstract: Diphenyl 2‐Pyridylphosphine and Di‐tert‐Butyl Azodicarboxylate: Convenient Reagents for the Mitsunobu Reaction.. ChemInform. 30(35).
6.
Vernier, Jean‐Michel, Nicholas D. P. Cosford, Jeffrey P. Whitten, et al.. (1998). Conformationally restricted analogues of nicotine and anabasine. Bioorganic & Medicinal Chemistry Letters. 8(16). 2173–2178. 34 indexed citations
7.
8.
Whitten, Jeffrey P., Yun Feng Xie, Thomas R. Webb, et al.. (1996). Rapid Microscale Synthesis, a New Method for Lead Optimization Using Robotics and Solution Phase Chemistry:  Application to the Synthesis and Optimization of Corticotropin-Releasing Factor1Receptor Antagonists. Journal of Medicinal Chemistry. 39(22). 4354–4357. 55 indexed citations
9.
Whitten, Jeffrey P., Bruce M. Baron, & Ian A. McDonald. (1993). Competitive NMDA receptor antagonists; (R)-4-Oxo-5-phosphononorvaline structure-activity relationships. Bioorganic & Medicinal Chemistry Letters. 3(1). 23–26. 8 indexed citations
10.
Yates, Mark T., Laurie E. Lambert, Jeffrey P. Whitten, et al.. (1992). A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Letters. 309(2). 135–138. 92 indexed citations
11.
Lambert, Laurie E., John F. French, Jeffrey P. Whitten, Bruce M. Baron, & Ian A. McDonald. (1992). Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. European Journal of Pharmacology. 216(1). 131–134. 44 indexed citations
12.
Whitten, Jeffrey P., Boyd L. Harrison, Herschel J. R. Weintraub, & Ian A. McDonald. (1992). Modeling of competitive phosphono amino acid NMDA receptor antagonists. Journal of Medicinal Chemistry. 35(9). 1509–1514. 11 indexed citations
13.
Lambert, Laurie E., Jeffrey P. Whitten, Bruce M. Baron, et al.. (1991). Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sciences. 48(1). 69–75. 152 indexed citations
14.
Kehne, John H., Timothy C. McCloskey, Bruce M. Baron, et al.. (1991). NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. European Journal of Pharmacology. 193(3). 283–292. 112 indexed citations
15.
McCarthy, James R., Donald P. Matthews, Robert J. Broersma, et al.. (1990). 1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine .beta.-hydroxylase. Journal of Medicinal Chemistry. 33(7). 1866–1873. 6 indexed citations
16.
Whitten, Jeffrey P., et al.. (1990). (R)-4-Oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex. Journal of Medicinal Chemistry. 33(11). 2961–2963. 36 indexed citations
17.
Matthews, Donald P., et al.. (1990). Synthesis and cardiotonic activity of novel biimidazoles. Journal of Medicinal Chemistry. 33(1). 317–327. 38 indexed citations
18.
Whitten, Jeffrey P., James R. McCarthy, & Donald P. Matthews. (1988). Cyanogen Bromide-Dimethylaminopyridine (CAP): A Convenient Source ofPositive Cyanidefor the Synthesis of 2-Cyanoimidazoles. Synthesis. 1988(6). 470–472. 17 indexed citations
19.
Matthews, Donald P., Jeffrey P. Whitten, & James R. McCarthy. (1987). Halogenation of [2‐(trimethylsilyl)ethoxy]methyl (SEM) protected 2,2′‐Bi‐H‐imidazole. Journal of Heterocyclic Chemistry. 24(3). 689–692. 11 indexed citations
20.
Matthews, Donald P., Jeffrey P. Whitten, & James R. McCarthy. (1986). A facile synthesis of aromatic trifluoromethyl compounds via orthothio esters. Tetrahedron Letters. 27(40). 4861–4864. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026